Literature DB >> 15767337

Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.

Rebecca E Rudolph1, Jason A Dominitz, Johanna W Lampe, Lisa Levy, Pingping Qu, Shuying S Li, Paul D Lampe, Mary P Bronner, John D Potter.   

Abstract

Several characteristics of aberrant crypt foci (ACF) suggest that they are precursors of colorectal cancer, but the factors that promote or inhibit their growth are largely unknown. We conducted a pilot study to explore whether factors associated with risk of colorectal cancer are also associated with number or size of rectal ACF. Thirty-two U.S. veterans, ages 50 to 80 years, were recruited to undergo magnifying chromoendoscopy for imaging of rectal ACF and colonoscopy for identification of polyps or cancer. Participants completed a questionnaire on cigarette smoking, use of nonsteroidal anti-inflammatory drugs (NSAIDs), and family history of colorectal cancer. Fisher's exact test was used to assess the statistical significance of associations between colorectal cancer risk factors and characteristics of ACF. Cochran-Mantel-Haenszel statistics and polytomous regression were used to test the significance of associations adjusted for age. Participants with a history of adenoma had more ACF than those without (age-adjusted P = 0.02), but the numbers in the two groups overlapped markedly. Older participants had more (P = 0.06) and larger (P = 0.009) ACF than younger participants. No associations were identified between either ACF number or size and cigarette smoking, use of NSAIDs, or family history of colorectal cancer. These findings suggest that persons with adenomas have somewhat more rectal ACF than persons without, and that older age is a risk factor for ACF growth. Future research should be directed toward developing techniques to identify ACF that are likely to progress to cancer and the modifiable factors that promote or inhibit such progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767337     DOI: 10.1158/1055-9965.EPI-04-0058

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

Review 1.  Accumulation of aberrant DNA methylation during colorectal cancer development.

Authors:  Eiji Sakai; Atsushi Nakajima; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

2.  Effect of eriodictyol on preneoplastic lesions, oxidative stress and bacterial enzymes in 1,2-dimethyl hydrazine-induced colon carcinogenesis.

Authors:  P Mariyappan; T Kalaiyarasu; V Manju
Journal:  Toxicol Res (Camb)       Date:  2017-06-19       Impact factor: 3.524

3.  Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.

Authors:  Paul J Limburg; Michelle R Mahoney; Katie L Allen Ziegler; Stephen J Sontag; Robert E Schoen; Richard Benya; Michael J Lawson; David S Weinberg; Elena Stoffel; Michael Chiorean; Russell Heigh; Joel Levine; Gary Della'Zanna; Luz Rodriguez; Ellen Richmond; Christopher Gostout; Sumithra J Mandrekar; Thomas C Smyrk
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

4.  The distribution of human rectal aberrant crypt foci and criteria for defining the counting area.

Authors:  Tetsuro Fujii; Eiji Sakai; Hirokazu Takahashi; Eiji Yamada; Hidenori Ohkubo; Takuma Higurashi; Atsushi Nakajima
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

Review 5.  Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies.

Authors:  Richard G Stevens; Helen Swede; Daniel W Rosenberg
Journal:  Cancer Lett       Date:  2006-12-19       Impact factor: 8.679

6.  Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.

Authors:  Pedro Figueiredo; Maria Donato; Marta Urbano; Helena Goulão; Hermano Gouveia; Carlos Sofia; Maximino Leitão; Diniz Freitas
Journal:  Int J Colorectal Dis       Date:  2008-09-04       Impact factor: 2.571

7.  Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

Authors:  Akshay K Gupta; Paul Pinsky; Christopher Rall; Matthew Mutch; Sarah Dry; David Seligson; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2009-06-21       Impact factor: 9.427

Review 8.  Early detection of colon cancer: new tests on the horizon.

Authors:  Akshay K Gupta; Dean E Brenner; D Kim Turgeon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Probe-based confocal laser endomicroscopy evaluation of colon preneoplastic lesions, with particular attention to the aberrant crypt foci, and comparative assessment with histological features obtained by conventional endoscopy.

Authors:  Massimo Mascolo; Stefania Staibano; Gennaro Ilardi; Maria Siano; Maria Luisa Vecchione; Dario Esposito; Gaetano De Rosa; Giovanni Domenico De Palma
Journal:  Gastroenterol Res Pract       Date:  2012-04-08       Impact factor: 2.260

10.  Post-initiation chlorophyllin exposure does not modulate aflatoxin-induced foci in the liver and colon of rats.

Authors:  Gayle A Orner; Bill D Roebuck; Roderick H Dashwood; George S Bailey
Journal:  J Carcinog       Date:  2006-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.